The global human identification market size was estimated at USD 2.94 billion in 2025 and is predicted to increase from USD 3.17 billion in 2026 to approximately USD 6.25 billion by 2035, expanding at a CAGR of 7.84% from 2026 to 2035. Expanding healthcare digitalization is promoting the adoption of human identification solutions. Growing R&D activities, patient volumes, technological innovations, government support, and new platforms launched are also enhancing the market growth.
The human identification market is driven by growing crime rates, DNA databases, and a shift towards high-throughput NGS. Human identification refers to the recognition and verification of a person’s physical, behavioral, and biological characteristics. It is used for patient verification, crime investigation, the prevention of fraud, maintaining medical records, and ensuring healthcare safety.
AI offers a wide range of applications in the human identification systems development by offering facial recognition, voice recognition, and fingerprint analysis features. It also helps in fraud detection, behavior analysis, and medial record maintenance. AI can also be used for real-time authentication and maintaining the data security of sensitive patient information.
Healthcare Digitalization
The growing adoption of various digital health tools and services is promoting the adoption of human identification systems. They are promoting secure remote patient consultation, monitoring, and enhancing patient outcomes.
Rise of Biometric Technologies
In order to enhance patient verification, medical record security, and hospital access, the use of biometric systems is increasing. They help in recognizing fingerprints, iris, and facial features, with faster scanning.
Expanding Features
To minimize cyberattacks and data breaches and offer rapid DNA analysis for forensic applications, companies are introducing new features. Multifactor authentication, secure cloud storage, disease prediction, genetic testing, etc., are being integrated into human identification systems.
| Table | Scope |
| Market Size in 2026 | USD 3.17 Billion |
| Projected Market Size in 2035 | USD 6.25 Billion |
| CAGR (2026 - 2035) | 7.84% |
| Leading Region | North America by 39% |
| Key Applications | Forensic investigations, paternity testing, criminal identification, disaster victim identification, military identification, clinical diagnostics, population genetics research |
| Primary End Users | Forensic laboratories, law enforcement agencies, hospitals, diagnostic centers, military organizations, research institutes, biotechnology companies |
| Key Growth Drivers | Expansion of forensic databases, increasing DNA testing demand, adoption of NGS technologies, government investments in forensic infrastructure, AI-powered genomic analysis |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Technology, By Product, By Application, By End User, By Sample Type, By Region |
| Top Key Players | Thermo Fisher Scientific Inc., Hamilton Company, QIAGEN N.V., Bio-Rad Laboratories, Inc., Promega Corporation, LGC Limited, Illumina, Inc., AutoGen Inc., Agilent Technologies, Inc., ANDE Corporation |
| Segment | Share 2025 (%) |
| PCR-based Human Identification | 41% |
| Capillary Electrophoresis | 24% |
| Next-Generation Sequencing (NGS) | 18% |
| Rapid DNA Technology | 11% |
| Microarray Technology | 6% |
The PCR-based Human Identification Segment Dominated the Market With 41% in 2025
The PCR-based human identification segment led the human identification market with 41% share in 2025, due to its extensive adoption in forensic laboratories, which supported consistent testing demand. Their high analytical accuracy improved criminal investigation efficiency. Established regulatory acceptance also strengthened its global implementation.
The capillary electrophoresis segment held the second-largest share of 24% of the market in 2025, driven by increasing DNA profiling volume, which accelerates automated CE platform deployment. Laboratories prefer standardized workflows for faster throughput, promoting their use. Government funding supporting forensic modernization programs is also increasing its demand.
The next-generation sequencing (NGS) segment held 18% of the human identification market share in 2025 and is expected to witness the fastest growth with a CAGR of 10.90% during the forecast period, due to advanced genomic analysis capabilities and expanding complex identification applications. Declining sequencing costs also improve their accessibility across laboratories. Multi-marker analysis also enhances forensic precision and sensitivity.
The rapid DNA technology segment held 11% of the market share in 2025, driven by border security and field-based identification needs, which accelerate its adoption. Their portable analyzers reduce turnaround time significantly, enhancing their adoption. Real-time law enforcement decision-making also drives investments.
| Segment | Share 2025 (%) |
| Instruments | 33% |
| Consumables | 46% |
| Software | 9% |
| Services | 12% |
The Consumables Segment Dominated the Market With 46% in 2025
The consumables segment accounted for the highest revenue share of 46% of the human identification market in 2025, due to recurring demand for reagents and kits. Growth in DNA testing volumes also increased consumable usage. Continuous assay innovation also increased their adoption rates.
The instruments segment held the second-largest share of 33% of the market in 2025, due to increasing demand for advanced sequencing and PCR systems. Government agencies continue upgrading forensic infrastructure, increasing their demand. High-throughput platforms also improve operational efficiency.
The services segment held 12% of the human identification market share in 2025, driven by the growing outsourced forensic testing demand among smaller laboratories. Specialized DNA profiling services also improve scalability, promoting their use. Rising legal DNA testing also supports service expansion.
The software segment held 9% of the market share in 2025 and is expected to show the highest growth with a CAGR of 9.40% during the forecast period, due to AI-enabled forensic analytics, which enhances interpretation efficiency. Integration with forensic databases also improves case management. Cloud-based bioinformatics platforms are also expanding accessibility.
| Segment | Share 2025 (%) |
| Forensic Applications | 44% |
| Paternity & Kinship Testing | 23% |
| Clinical Diagnostics | 14% |
| Research Applications | 11% |
| Military & Defense Identification | 8% |
The Forensic Applications Segment Dominated the Market With 44% in 2025
The forensic applications segment held a major revenue share of 44% of the human identification market in 2025, due to increased criminal investigations, which strengthened forensic DNA utilization. Their national DNA databases also improved identification efficiency. Growth in government investments also expanded forensic capabilities globally.
The paternity & kinship testing segment held the second-largest share of 23% of the market in 2025, driven by rising awareness of legal identity verification, which supports market growth. Growing adoption of home DNA testing also increases its accessibility. International migration trends also increase kinship testing demand.
The clinical diagnostics segment held 14% of the human identification market share in 2025, due to precision medicine adoption drives genetic identification applications. Growing hospitals are integrating DNA-based diagnostics, promoting the use of human identification. Technological improvements also enhance clinical reliability.
The military & defense identification segment held 8% of the market share in 2025 and is expected to expand rapidly with a CAGR of 9.70% during the forecast period, due to defense agencies strengthening personnel identification capabilities. Their rapid DNA analysis also supports battlefield operations. Cross-border security concerns also increase their adoption.
| Segment | Share 2025 (%) |
| Forensic Laboratories | 38% |
| Hospitals & Diagnostic Centers | 19% |
| Academic & Research Institutes | 13% |
| Law Enforcement Agencies | 16% |
| Military Organizations | 7% |
| Biotechnology & Pharmaceutical Companies | 7% |
The Forensic Laboratories Segment Dominated the Market With 38% in 2025
The forensic laboratories segment contributed the biggest revenue share of 38% of the human identification market in 2025, due to rising criminal case backlogs, which increased DNA testing requirements. Government modernization programs also supported laboratory expansion, promoting human identification systems' adoption. Automation technologies also improved testing efficiency.
The hospitals & diagnostic centers segment held the second-largest share of 19% of the market in 2025, due to clinical genomics adoption, which accelerates diagnostic identification testing. Hospitals are also integrating advanced sequencing technologies. Growing personalized medicine trends also expand their usage.
The law enforcement agencies segment held 16% of the human identification market share in 2025, driven by real-time identification requirements, which strengthen DNA technology adoption. National security initiatives also increase forensic investments, promoting the use of human identification solutions. Digital forensic integration also enhances operational effectiveness.
The military organizations segment held 7% of the market share in 2025 and is expected to gain the highest share with a CAGR of 9.40% during the forecast period, due to defense modernization programs encouraging the use of advanced identification systems. Portable DNA technologies also improve field operations, driving their demand. International security concerns also sustain their procurement growth.
| Segment | Share 2025 (%) |
| Blood Samples | 34% |
| Saliva/Buccal Swabs | 29% |
| Hair Samples | 11% |
| Bone & Teeth Samples | 13% |
| Tissue Samples | 8% |
| Other Biological Samples | 5% |
The Blood Samples Segment Dominated the Market With 34% in 2025
The blood samples segment held the largest revenue share of 34% of the human identification market in 2025, driven by high DNA yield and reliability, which maintained widespread forensic preference. Clinical laboratories extensively use blood-based testing solutions. Their standardized protocols also improved analytical consistency.
The saliva/buccal swabs segment held the second-largest share of 29% of the market in 2025 and is expected to grow with the fastest CAGR of 8.70% during the forecast period, due to their non-invasive collection methods improving adoption across applications. Home-based DNA testing also boosts consumer demand. Faster collection procedures also enhance operational convenience.
The bone & teeth samples segment held 13% of the human identification market share in 2025, due to disaster victim identification, which increases skeletal sample analysis demand. Military applications also strengthen forensic utilization. Advanced extraction methods also improve degraded DNA recovery, promoting their use.
The hair samples segment held 11% of the market share in 2025, driven by hair-based forensic analysis, which supports criminal investigations effectively. Improved extraction technologies also increase testing sensitivity. Long-term evidence preservation also supports their usage.
North America dominated the human identification market with 39% in 2025, due to a strong forensic infrastructure that supported large-scale DNA profiling adoption. Growth in federal funding also accelerated laboratory modernization initiatives. High criminal database penetration also contributed to the market growth.
U.S. Market Trends
Large forensic databases and advanced laboratories in the U.S. are sustaining its market leadership. Increasing federal grants are also accelerating technology upgrades. Strong adoption of NGS and rapid DNA systems is also supporting human identification expansion.
Asia Pacific held 22% share of the human identification market in 2025 and is expected to grow at the fastest CAGR of 9.80% during the forecast period, due to rapid forensic infrastructure expansion. Increasing population and crime investigation activities are also supporting human identification solutions adoption. Government genomic initiatives are stimulating investments and enhancing market growth.
China Market Trends
Growing large-scale national genomic programs in China are driving the market expansion. Strong government investments in improving forensic capabilities are also promoting the adoption of human identification solutions. Increasing law enforcement adoption also drives their demand.
| Ecosystem Segment | Key Participants | Role in Market |
| Technology Providers | Illumina, Thermo Fisher Scientific, QIAGEN | Develop sequencing, PCR, and DNA analysis technologies |
| Product Manufacturers | Promega, Bio-Rad Laboratories, Agilent Technologies | Manufacture instruments, reagents, assays, and forensic testing kits |
| Service Providers | Labcorp, Eurofins Scientific, Bode Technology | Provide DNA testing, forensic services, and identity verification solutions |
| Platform Providers | Thermo Fisher Scientific, QIAGEN, Illumina | Integrated forensic genomics and DNA analysis platforms |
| CROs/CDMOs | Eurofins Scientific, Labcorp Drug Development | Support genetic analysis, sample processing, and laboratory services |
| Software Vendors | Verogen, GeneCodes, QIAGEN Digital Insights | DNA profile analysis, forensic bioinformatics, case management software |
| Research Institutions | FBI Laboratory, National Institute of Standards and Technology (NIST), National Center for Biotechnology Information (NCBI) | Method validation, standards development, forensic research |
| End-User Industries | Forensics, Healthcare, Defense, Law Enforcement, Research | Utilize human identification technologies for operational and investigative purposes |
R&D
Clinical Trials and Regulatory Approvals
Patient Support and Services
| Tier 1 | Tier 2 | Tier 3 | |
| Typical Market Influence | 62% | 25% | 13% |
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| Thermo Fisher Scientific | Waltham, Massachusetts | USA | Global leader in forensic genomics and human identification workflows | Applied Biosystems HID Systems, RapidHIT, STR Kits |
| Illumina | San Diego, California | USA | Dominant NGS provider for forensic genomics and DNA profiling | MiSeq FGx, ForenSeq DNA Signature Prep Kit |
| QIAGEN N.V. | Venlo | Netherlands | Major provider of DNA extraction and forensic analysis solutions | Investigator Kits, QIAcube, QIAsymphony |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| Agilent Technologies | Santa Clara, California | USA | Important provider of electrophoresis and genomic analysis tools | Automated Electrophoresis Systems |
| Eurofins Scientific | Luxembourg City | Luxembourg | Large forensic and genomic testing service provider | DNA Testing and Forensic Services |
| Labcorp | Burlington, North Carolina | USA | Significant provider of identity testing and genomic services | Paternity Testing, DNA Analysis Services |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services |
| ANDE Corporation | Waltham, Massachusetts | USA | Pioneer in rapid DNA technology | ANDE Rapid DNA System |
| Verogen | San Diego, California | USA | Specialized forensic genomics company focused on NGS | ForenSeq Solutions |
| AutoGen Inc. | Holliston, Massachusetts | USA | Focused on automated DNA extraction technologies | FlexSTAR Extraction Systems |
Strengths
Weaknesses
Opportunities
Threats
By Technology
By Product
By Application
By End User
By Sample Type
By Region
Principal Consultant
Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.
Learn more about Shivani Zoting
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi Shivarkar
+1 804-441-9344
